Cargando…
A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
(1). An essential component of any treatment for patients with irritable bowel syndrome (IBS) is an adequate diet. Currently, a low FODMAP diet is recommended as a first-line therapy, but it does not relieve abdominal discomfort in all patients, and alternative nutritional treatment is required. The...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738361/ https://www.ncbi.nlm.nih.gov/pubmed/36499643 http://dx.doi.org/10.3390/ijms232315314 |
_version_ | 1784847522195308544 |
---|---|
author | Chojnacki, Cezary Medrek-Socha, Marta Blonska, Aleksandra Zajdel, Radoslaw Chojnacki, Jan Poplawski, Tomasz |
author_facet | Chojnacki, Cezary Medrek-Socha, Marta Blonska, Aleksandra Zajdel, Radoslaw Chojnacki, Jan Poplawski, Tomasz |
author_sort | Chojnacki, Cezary |
collection | PubMed |
description | (1). An essential component of any treatment for patients with irritable bowel syndrome (IBS) is an adequate diet. Currently, a low FODMAP diet is recommended as a first-line therapy, but it does not relieve abdominal discomfort in all patients, and alternative nutritional treatment is required. The purpose of this study was to evaluate the effect of a tryptophan-lowering diet (TRP) on abdominal and mental symptoms in patients with irritable bowel syndrome with predominant diarrhea (IBS-D). (2). The study included 40 patients with IBS-D, and 40 healthy subjects served as a baseline for IBS-D patients, after excluding comorbidities. The TRP intake was calculated using the nutritional calculator. The severity of abdominal symptoms was assessed using the gastrointestinal symptom rating scale (GSRS-IBS). Mental state was assessed using the Hamilton anxiety rating scale (HAM-A), the Hamilton depression rating scale (HAM-D), and the insomnia severity index (ISI). The serum levels of serotonin and melatonin and the urinary excretion of their metabolites 5-hydroxyindoleacetic acid (5-HIAA) and 6-sulfatoxymelatonin (aMT6) were determined by the ELISA method. The severity of symptoms and laboratory data were analyzed before and after a 12 week diet with tryptophan restricted to a daily dose 10 mg per kilogram body weight. (3). Compared to the control group, patients with IBS-D had a higher serum level of serotonin (198.2 ± 38.1 vs. 142.3 ± 36.4 ng/mL; p < 0.001) but a similar level of melatonin (8.6 ± 1.1 vs. 9.4 ± 3.0 pg/mL; p > 0.05). The urinary excretion of 5-HIAA was also higher in patients with IBS-D patients (7.7 ± 1.5 vs. 6.0 ± 1.7 mg/24 h; p < 0.001). After nutritional treatment, both the serum serotonin level and the urinary 5-HIAA excretion significantly decreased (p < 0.001). The severity of the abdominal symptoms and anxiety also decreased, while the HAM-D score and the ISI score remained unchanged (4). Lowering the dietary intake of tryptophan may reduce abdominal complaints and does not alter the mental state of IBS-D patients. |
format | Online Article Text |
id | pubmed-9738361 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97383612022-12-11 A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites Chojnacki, Cezary Medrek-Socha, Marta Blonska, Aleksandra Zajdel, Radoslaw Chojnacki, Jan Poplawski, Tomasz Int J Mol Sci Article (1). An essential component of any treatment for patients with irritable bowel syndrome (IBS) is an adequate diet. Currently, a low FODMAP diet is recommended as a first-line therapy, but it does not relieve abdominal discomfort in all patients, and alternative nutritional treatment is required. The purpose of this study was to evaluate the effect of a tryptophan-lowering diet (TRP) on abdominal and mental symptoms in patients with irritable bowel syndrome with predominant diarrhea (IBS-D). (2). The study included 40 patients with IBS-D, and 40 healthy subjects served as a baseline for IBS-D patients, after excluding comorbidities. The TRP intake was calculated using the nutritional calculator. The severity of abdominal symptoms was assessed using the gastrointestinal symptom rating scale (GSRS-IBS). Mental state was assessed using the Hamilton anxiety rating scale (HAM-A), the Hamilton depression rating scale (HAM-D), and the insomnia severity index (ISI). The serum levels of serotonin and melatonin and the urinary excretion of their metabolites 5-hydroxyindoleacetic acid (5-HIAA) and 6-sulfatoxymelatonin (aMT6) were determined by the ELISA method. The severity of symptoms and laboratory data were analyzed before and after a 12 week diet with tryptophan restricted to a daily dose 10 mg per kilogram body weight. (3). Compared to the control group, patients with IBS-D had a higher serum level of serotonin (198.2 ± 38.1 vs. 142.3 ± 36.4 ng/mL; p < 0.001) but a similar level of melatonin (8.6 ± 1.1 vs. 9.4 ± 3.0 pg/mL; p > 0.05). The urinary excretion of 5-HIAA was also higher in patients with IBS-D patients (7.7 ± 1.5 vs. 6.0 ± 1.7 mg/24 h; p < 0.001). After nutritional treatment, both the serum serotonin level and the urinary 5-HIAA excretion significantly decreased (p < 0.001). The severity of the abdominal symptoms and anxiety also decreased, while the HAM-D score and the ISI score remained unchanged (4). Lowering the dietary intake of tryptophan may reduce abdominal complaints and does not alter the mental state of IBS-D patients. MDPI 2022-12-05 /pmc/articles/PMC9738361/ /pubmed/36499643 http://dx.doi.org/10.3390/ijms232315314 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chojnacki, Cezary Medrek-Socha, Marta Blonska, Aleksandra Zajdel, Radoslaw Chojnacki, Jan Poplawski, Tomasz A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites |
title | A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites |
title_full | A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites |
title_fullStr | A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites |
title_full_unstemmed | A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites |
title_short | A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites |
title_sort | reduced tryptophan diet in patients with diarrhoea-predominant irritable bowel syndrome improves their abdominal symptoms and their quality of life through reduction of serotonin levels and its urinary metabolites |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738361/ https://www.ncbi.nlm.nih.gov/pubmed/36499643 http://dx.doi.org/10.3390/ijms232315314 |
work_keys_str_mv | AT chojnackicezary areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT medreksochamarta areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT blonskaaleksandra areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT zajdelradoslaw areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT chojnackijan areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT poplawskitomasz areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT chojnackicezary reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT medreksochamarta reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT blonskaaleksandra reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT zajdelradoslaw reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT chojnackijan reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites AT poplawskitomasz reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites |